Andreas Mahler

Nonmotor fluctuations in Parkinson disease

Alexander Storch, Christine Schneider, Martin Wolz et al. · Neurology · 2013 · 354 citations

Medicine, Neurology, Neuroscience +17

A Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of the H<sub>3</sub> Receptor Antagonist, GSK239512 as a Monotherapy in Subjects with Mild-to-Moderate Alzheimer’s Disease

Richard Grove, Conn Harrington, Andreas Mahler et al. · Current Alzheimer Research · 2014 · 109 citations

Medicine, Pharmacology, Pharmacotherapy +17

Comparison of IPX066 with carbidopa–levodopa plus entacapone in advanced PD patients

Fabrizio Stocchi, Ann Hsu, Sarita Khanna et al. · Parkinsonism & Related Disorders · 2014 · 74 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies

Olivier Rascol, Lars Tönges, Tina deVries et al. · Parkinsonism & Related Disorders · 2022 · 21 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Combination treatment of fingolimod with antidepressants in relapsing–remitting multiple sclerosis patients with depression: a multicentre, open-label study – REGAIN

Antonios Bayas, Katrin Schuh, Monika Baier et al. · Therapeutic Advances in Neurological Disorders · 2016 · 19 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16